The impact of minor histocompatibility antigens in allogeneic stem cell transplantation - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 52

[5] Thomas ED, Buckner CD, Rudolph RH, Fefer A, Storb R, Neiman PE, et al. Allogeneic
marrow grafting for hematologic malignancy using HL-A matched donor-recipient
sibling pairs. Blood 1971;38:267-87.
[6] van Rood JJ, van Leeuwen A, Goulmy E, Termijtelen A, Bradley BA, Brand A, et al. The
importance of non-HLA systems and the feasibility of the use of unrelated donors in
bone marrow transplantation. Transplant Proc 1978;10:47-51.
[7] Petersdorf EW. HLA matching in allogeneic stem cell transplantation. Curr Opin
Hematol 2004;11:386-91.
[8] Shaw BE, Madrigal JA, Potter M. Improving the outcome of unrelated donor stem cell
transplantation by molecular matching. Blood Rev 2001;15:167-74.
[9] van Rood JJ, van Leeuwen A, Persijn GG, Lansbergen Q, Goulmy E, Termijtelen A, et al.
Role of the HLA system in transplantation. HLA compatibility in clinical transplanta-
tion. Transplant Proc 1977;9:459-67.
[10] Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women
is restricted by HLA. Nature 1977;266:544-5.
[11] Barth R, Counce S, Smith P, Snell GD. Strong and weak histocompatibility gene differ-
ences in mice and their role in the rejection of homografts of tumors and skin. Ann Surg
1956;144:198-204.
[12] Roopenian D, Choi EY, Brown A. The immunogenomics of minor histocompatibility
antigens. Immunol Rev 2002;190:69-87.
[13] Choi EY, Christianson GJ, Yoshimura Y, Sproule TJ, Jung N, Joyce S, et al. Immunodomi-
nance of H60 is caused by an abnormally high precursor T cell pool directed against its
unique minor histocompatibility antigen peptide. Immunity 2002;17:593-603.
[14] Eden PA, Christianson GJ, Fonyaine P, Wettstein PJ, Perreault C, Roopenian C.
Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1)
encoded by the classical H7 minor histocompatibility locus. J Immunol 1999;1999
(192):4502-10.
[15] van Bergen CA, Rutten CE, van der Meijden ED, van Luxemburg-Heys SA, Lurvink EG,
Houwing-Duistermaat JJ, et al. High-throughput characterization of 10 new minor
histocompatibility antigens by whole genome association scanning. Cancer Res
2010;70:9073-83.
[16] Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C. Adoptive transfer of
minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells
without causing graft-versus-host disease. Trends Immunol 2001;97:2886-95.
[17] Li N, Matte-Martone C, Zheng H, Cui W, Venkatesan S, Tan HS, et al. Memory T cells
from minor histocompatibility antigen-vaccinated and virus-immune donors improve
GVL and immune reconstitution. Blood 2011;118:1528.
[18] Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation
antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host
disease. Nature 1983;302:159-61.
[19] Goulmy E, Blokland E, van Rood JJ, Charmot D, Malissen B, Mawas C. Production,
expansion, and clonal analysis of T cells with specific HLA-restricted male lysis. J Exp
Med 1980;152:182s-90s.
[20] Goulmy E, van Leeuwen A, Blokland E, van Rood JJ, Biddison WE. Major histocompat-
ibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may
recognize different self determinants. J Exp Med 1982;155:1567-72.
[21] Goulmy E. Class-I-restricted human cytotoxic T lymphocytes directed against minor
transplantation antigens and their possible role in organ transplantation. Prog Allergy
1985;36:44-72.
[22] van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E. Graft-versus-
host disease associated T helper cell responses specific for minor histocompatibil-
ity antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant
1990;5:365-72.
[23] Marijt WA, Veenhof WF, Brand A, Goulmy E, Fibbe WE, Willemze R, et al. Minor histo-
compatibility antigen-specific cytotoxic T cell lines, capable of lysing human hemato-
poietic progenitor cells, can be generated in vitro by stimulation with HLA-identical
bone marrow cells. J Exp Med 1991;173:101-9.
[24] Eibl B, Schwaighofer H, Nachbaur D, Marth C, Gachter A, Knapp R, et al. Evidence for a
graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and
allogeneic bone marrow transplantation for breast cancer. Blood 1996;88:1501-8.
[25] Dolstra H, Fredrix H, Preijers F, Goulmy E, Figdor CG, de Witte TM, et al. Recognition
of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol
1997;158:560-5.
[26] Warren III EH, Greenberg PD, Riddell SR. Cytotoxic T-lymphocyte-defined human
minor histocompatibility antigens with a restricted tissue distribution. Blood
1998;91:2197-207.

53